<?xml version="1.0" encoding="UTF-8"?>
<p id="par0250">HCoV-OC43 remains incessantly one of the most important etiological factors for respiratory tract diseases in humans. Recently, it was found that HCoV-OC43 employs caveolin-1 dependent endocytosis for the entry 
 <xref rid="bib0790" ref-type="bibr">[158]</xref>. Subsequently, cholesterol-binding or depleting agents such as nystatin (
 <bold>104</bold>, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) or methyl-β-cyclodextrin (MβCD) (
 <bold>105</bold>, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) were reported to inhibit the virus replication via an aveolin-1 caveolin-1 dependent endocytosis entry.
</p>
